Company · CIK 1807120
Design Therapeutics, Inc.
| CIK | 1807120 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | DSGN (Nasdaq) |
| First annual or quarterly report | 2021-05-10 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-287043 | 2025-05-07 | 2025-05-16 | 2 | |
| 333-264521 | 2022-04-27 | 2022-05-09 | 2 | |
| 333-253954 | 2021-03-05 | 2021-03-26 | 4 |
Filings
9| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-05-16 | EFFECTDeclared effective | 333-287043 | 9999999995-25-001643 |
| 2025-05-07 | S-3Shelf registered | 333-287043 | 0001193125-25-114986 |
| 2022-05-09 | EFFECTDeclared effective | 333-264521 | 9999999995-22-001375 |
| 2022-04-27 | S-3Shelf registered | 333-264521 | 0001193125-22-123965 |
| 2021-03-26 | 424B4Final prospectus | 333-253954 | 0001193125-21-096741 |
| 2021-03-25 | EFFECTDeclared effective | 333-253954 | 9999999995-21-001140 |
| 2021-03-22 | S-1/AAmendment | 333-253954 | 0001193125-21-088348 |
| 2021-03-05 | S-1Registration filed | 333-253954 | 0001193125-21-071667 |
| 2021-01-26 | DRSDraft made public | 377-04103 | 0000950123-21-000626 |